Skip to content
10-Q

Quarterly Report

GreenLight Biosciences Holdings, PBC

0000950170-22-017228

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 4, 2022 123.69M sh
Shares Diluted Q2 2022 · Jun 30, 2022 123.25M sh
Shares Diluted Q2 2022 · Jun 30, 2022 118.43M sh
Shares Diluted Q2 2022 · Jun 30, 2021 96.33M sh
Shares Diluted Q2 2022 · Jun 30, 2021 96.31M sh
Capex Q2 2022 · Jun 30, 2022 $12.87M
Capex Q2 2022 · Jun 30, 2021 $6.79M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$72.17M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$42.3M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $44.13M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $31.45M
Cash And Equivalents restated Q2 2022 · Jun 30, 2021 $52.34M
Stockholders Equity Q2 2022 · Jun 30, 2022 $13.73M
Stockholders Equity Q2 2022 · Mar 31, 2022 $63.83M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$29.98M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 $32.29M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 $59.04M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 $79.97M
Current Liabilities Q2 2022 · Jun 30, 2022 $55.22M
Current Liabilities Q2 2022 · Dec 31, 2021 $62.34M
Total Liabilities Q2 2022 · Jun 30, 2022 $85.09M
Total Liabilities Q2 2022 · Dec 31, 2021 $93.03M
Current Assets Q2 2022 · Jun 30, 2022 $64M
Current Assets Q2 2022 · Dec 31, 2021 $33.78M
Total Assets Q2 2022 · Jun 30, 2022 $98.81M
Total Assets Q2 2022 · Dec 31, 2021 $63.06M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.42
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.76
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.28
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.50
Eps Basic Q2 2022 · Jun 30, 2022 −$0.42
Eps Basic Q2 2022 · Jun 30, 2022 −$0.76
Eps Basic Q2 2022 · Jun 30, 2021 −$0.28
Eps Basic Q2 2022 · Jun 30, 2021 −$0.50
Sga Expense Q2 2022 · Jun 30, 2022 $9.58M
Sga Expense Q2 2022 · Jun 30, 2022 $19.33M
Sga Expense restated Q2 2022 · Jun 30, 2021 $4.93M
Sga Expense restated Q2 2022 · Jun 30, 2021 $8.83M
Net Income Q2 2022 · Jun 30, 2022 −$51.93M
Net Income Q2 2022 · Jun 30, 2022 −$90.13M
Net Income restated Q2 2022 · Jun 30, 2021 −$27.17M
Net Income restated Q2 2022 · Jun 30, 2021 −$48.46M
Operating Income Q2 2022 · Jun 30, 2022 −$51.96M
Operating Income Q2 2022 · Jun 30, 2022 −$88.74M
Operating Income restated Q2 2022 · Jun 30, 2021 −$26.45M
Operating Income restated Q2 2022 · Jun 30, 2021 −$47.43M
Revenue Q2 2022 · Jun 30, 2022 $1.77M
Revenue Q2 2022 · Jun 30, 2022 $2.03M
Revenue Q2 2022 · Jun 30, 2021 $493K
Revenue Q2 2022 · Jun 30, 2021 $818K